Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About MicroPort NeuroScientific
Its shares trade on HKEX under the ticker 2172.HK. It has been listed since 15 July 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥770.0m and net income of CN¥179.7m. At that date it held total assets of CN¥2.11bn and shareholders' equity of CN¥1.80bn.
MicroPort NeuroTech Ltd. operates as a medical device company, which manufactures neuro-interventional products to treat brain disease. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-07-15. The firm is principally engaged in the research and development, manufacturing and sales of neuro-interventional medical devices. The firm's main products include embolization coils, flow-diverting stents and stent grafts. The firm's products mainly cover three major areas of neurovascular diseases, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The firm mainly operates its businesses in the domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 15 Jul 2022
- Employees
- 580
- Website
- medneurotech.com ↗
Leadership
Pay as last reported
- Ms. Haixiao ZhangNon-Executive Independent Director
- Dr. Zhaohua ChangNon-Executive Chairman of the Board
- Mr. Zhiyong XiePresident, Executive Director, since 2020$3.6m
- Ms. Zhuoping HouAdvanced Director of Finance
- Mr. Yiqun WangExecutive Vice President, Executive Director, since 2020$2.9m
- Mr. Lei DuanVice President of Sales
- Ms. Zaoli WuSenior Director, Director of Human Resources and administration
- Ms. Huina LuSenior Director of Quality, Regulatory and Clinical affairs
- Mr. Weili XuSenior Director of promotion in South China
- Ms. Siu Lam YeungCompany Secretary
- Mr. Qingwei SunNon-Executive Director
- Ms. Xia WuNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MicroPort NeuroScientific Corp manufactures neuro-interventional products to treat brain disease.
- The firm employs 580 full-time employees in the Health Care sector.
- Main products include embolization coils, flow-diverting stents and stent grafts.
Weaknesses
- The company is headquartered in Shanghai, Shanghai, China.
- The firm went IPO on 15 July 2022.
- MicroPort NeuroTech Ltd. operates as a medical device company.
Opportunities
- The firm mainly operates its businesses in the domestic and overseas markets.
- Products cover hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
- The company is principally engaged in research and development of devices.
Threats
- The firm is principally engaged in the manufacturing and sales of devices.
- MicroPort NeuroScientific Corp operates in the competitive Health Care industry.
- The company faces risks in the domestic and overseas markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.